Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

DAVITA INC. Director's Dealing 2016

Dec 29, 2016

30643_dirs_2016-12-28_95d9d59c-f15c-4842-ad9c-b7688361ff45.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: DAVITA INC. (DVA)
CIK: 0000927066
Period of Report: 2016-12-24

Reporting Person: STAFFIERI MICHAEL DAVID (COO, Kidney Care)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2016-12-24 Restricted Stock Unit $ A 8186 Acquired Common Stock (8186) Direct

Footnotes

F1: Each restricted stock unit represents the right to receive one share of the Issuer's common stock upon settlement.

F2: These restricted stock units are scheduled to vest 50% on each of May 15, 2019 and May 15, 2020, subject to continued service through each applicable vesting date.